SCHEMBL8882086

SCHEMBL8882086

CCN(CCCC1CCN(CC(=O)N2c3ccc(Cl)cc3C(=O)Nc3cccnc32)CC1)C(=O)C1CC1

nearest known ligand 0.81

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 9/20 0.81
CHRM1 P11229 9/20 0.81
CHRM3 P20309 8/20 0.81
CHRM4 P08173 5/20 0.81
CHRM5 P08912 4/20 0.81
ALOX15 P16050 1/20 0.65
DRD1 P21728 1/20 0.65
DRD5 P21918 1/20 0.65
TMEM97 Q5BJF2 1/20 0.65
LMNA P02545 2/20 0.49
USP2 O75604 1/20 0.49
ALDH1A1 P00352 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2D6 P10635 1/20 0.49
GMNN O75496 1/20 0.49
APEX1 P27695 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8881033 0.97 CHRM2 (0.79) CHRM2CHRM1CHRM3CHRM4CHRM5
SCHEMBL8879428 0.94 CHRM2 (0.82) CHRM2CHRM1CHRM3CHRM4CHRM5
SCHEMBL8881459 0.92 CHRM2 (0.89) CHRM2CHRM1CHRM3CHRM4CHRM5
SCHEMBL8878832 0.91 CHRM2 (0.83) CHRM2CHRM1CHRM3CHRM4CHRM5
SCHEMBL8881358 0.90 CHRM2 (0.82) CHRM2CHRM1CHRM3CHRM4CHRM5
SCHEMBL8881870 0.90 CHRM2 (0.91) CHRM2CHRM1CHRM3CHRM4CHRM5
SCHEMBL194898 0.90 CHRM2 (1.00) CHRM2CHRM1CHRM3CHRM4CHRM5
SCHEMBL29504161 0.90 CHRM2 (1.00) CHRM2CHRM1CHRM3CHRM4CHRM5
SCHEMBL8879988 0.90 CHRM2 (0.85) CHRM2CHRM1CHRM3CHRM4CHRM5
SCHEMBL9042607 0.89 CHRM2 (0.77) CHRM2CHRM1CHRM3CHRM4CHRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5641772-A Condensed diazepinones, processes for preparing them and agents containing these compounds for treating diseases of the central nervous system and for promoting cerebral blood circulation DR. KARL THOMAE GMBH (DE) 1997-06-24 US disclosed
US-5610155-A ALZHEIMER'S DR. KARL THOMAE GMBH (DE) 1997-03-11 US disclosed
EP-0508370-B1 Condensed diazepinones, process for their preparation and compositions containing them for the treatment of the central nervous system and to enhance cerebral perfusion THOMAE GMBH DR K (DE) 1996-07-03 EP disclosed
EP-0508370-A1 Condensed diazepinones, process for their preparation and compositions containing them for the treatment of the central nervous system and to enhance cerebral perfusion Dr. Karl Thomae GmbH (DE) 1992-10-14 EP disclosed